Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-β-dependent and -independent mechanisms

Cancer Research

Volumn 61, Issue 21, 2001, Pages 7830-7839

  Miao, Wei Min ^a   Seng, Wen Lin ^a   Duquette, Mark ^a   Lawler, Patrick ^a   Laus, Christiane ^a   Lawler, Jack ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCOLLAGEN; RECOMBINANT PROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DROSOPHILA; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEWIS CARCINOMA; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL DIVISION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; GROWTH INHIBITORS; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035503689     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. The hallmarks of cancer
2. Landscaping the cancer terrain
3. Tumout suppressor genes and angiogenesis: The role of TP53 in fibroblasts
4. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis and tumor progression
5. Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells
6. The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression
7. Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma
8. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
9. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization
10. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas
11. Thromhospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells
12. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis
13. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
14. Thrombospondin as an inhibitor of angiogenesis
15. Endothelial cell mitogenesis induced by LPA
16. Thrombospondin I and type I repeat peptides of thrombospondin I specifically induce apoptosis of endothelial cells
17. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
18. Antiproliferative and antitumor activities of p-reversed peptides derived from the second type I repeat of thrombospondin-1
19. Inhibition of angiogenesis by thrombospondin-1 is mediated by two independent regions within the type I repeats
20. Three distinct p-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat
21. CD36 mediates the in vitro inhibitory effects of thromhospondin-I on endothelial cells
22. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
23. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system
24. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1
25. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia
26. Thrombospondin-1 is a major activator of TGF-β1 vivo
27. Inhibition and promotion of differentiated-like phenotype of a human lung carcinoma in athymic mice by natural and recombinant forms of transforming growth factor-β
28. Transforming growth factor β suppresses nonmetastatic colon cancer at an early stage of tumorigenesis
29. Transforming growth factor-β is a new form of tumor suppressor with true haploid insufficiency
30. Blocking transforming growth factor signaling in transgenic epidermis accelerates chemical carcinogenesis: A mechanism associated with increased angiogenesis
31. A proliferative effect of transforming growth factor-β on a human prostate cancer cell line, TSU-Prl
32. Transforming growth factor β (TGF β is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF β antisense expression plasmid
33. Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma
34. Transforming growth factor β1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma
35. Cell type-specific adhesive interactions of skeletal myoblasts with thrombospondin-1
36. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism
37. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: Modulation of platelet aggregation
38. A simple immunological protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells
39. Integrin α1β1 and transforming growth factor-β play distinct roles in Alport glomerular pathogenesis and serve as dual targets for metabolic therapy
40. Interaction of recombinant procollagen and properdin modules of thrombospondin-1 with heparin and fibrinogen/fibrin
41. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
42. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
43. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
44. Vascular biology of CD36: Roles of this new adhesion molecule family in different disease states
45. Role of thrombospondin-1-derived peptide, 4NIK, in FGF-2-induced angiogenesis
46. Anti-angiogenic therapy of transgenic mice impairs de novo tumor growth
47. Variation in apoptosis during multi-stage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors
48. Differential roles of protein kinase C and pertussis toxin-sensitive G-proteins in modulation of melanoma cell proliferation and motility by thrombospondin-1
49. Restoration of transforming growth factor β signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-medicated apoptosis 1
50. Transforming growth factor-β: Vasculogenesis, angiogenesis and vessel wall integrity